nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Gemcitabine—pancreatic cancer	0.166	0.225	CbGbCtD
Tenofovir—ABCC10—Docetaxel—pancreatic cancer	0.108	0.147	CbGbCtD
Tenofovir—ABCC10—Doxorubicin—pancreatic cancer	0.0807	0.11	CbGbCtD
Tenofovir—ABCC4—Fluorouracil—pancreatic cancer	0.0681	0.0926	CbGbCtD
Tenofovir—ABCC2—Tamoxifen—pancreatic cancer	0.055	0.0748	CbGbCtD
Tenofovir—ABCC4—Sunitinib—pancreatic cancer	0.0518	0.0704	CbGbCtD
Tenofovir—ABCC2—Irinotecan—pancreatic cancer	0.0422	0.0574	CbGbCtD
Tenofovir—ABCC2—Docetaxel—pancreatic cancer	0.0309	0.0421	CbGbCtD
Tenofovir—ABCC2—Sunitinib—pancreatic cancer	0.0308	0.0419	CbGbCtD
Tenofovir—CYP1A2—Dacarbazine—pancreatic cancer	0.0258	0.035	CbGbCtD
Tenofovir—ABCC2—Doxorubicin—pancreatic cancer	0.0231	0.0314	CbGbCtD
Tenofovir—CYP1A2—Tamoxifen—pancreatic cancer	0.0205	0.0279	CbGbCtD
Tenofovir—CYP1A2—Erlotinib—pancreatic cancer	0.0174	0.0237	CbGbCtD
Tenofovir—CYP1A2—Fluorouracil—pancreatic cancer	0.0151	0.0205	CbGbCtD
Tenofovir—ABCC2—bile duct—pancreatic cancer	0.00886	0.287	CbGeAlD
Tenofovir—ABCC2—bile—pancreatic cancer	0.00681	0.221	CbGeAlD
Tenofovir—Cidofovir—TYMP—pancreatic cancer	0.00551	0.536	CrCbGaD
Tenofovir—NME2—islet of Langerhans—pancreatic cancer	0.00318	0.103	CbGeAlD
Tenofovir—NME1—Gefitinib—Erlotinib—pancreatic cancer	0.00275	0.7	CbGdCrCtD
Tenofovir—NME2—pancreas—pancreatic cancer	0.00223	0.0725	CbGeAlD
Tenofovir—NME1—digestive system—pancreatic cancer	0.00203	0.0657	CbGeAlD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—SNAI1—pancreatic cancer	0.00198	0.034	CbGpPWpGaD
Tenofovir—AK4—digestive system—pancreatic cancer	0.00195	0.0633	CbGeAlD
Tenofovir—AK2—Nucleotide metabolism—DPYD—pancreatic cancer	0.00192	0.0329	CbGpPWpGaD
Tenofovir—NME2—digestive system—pancreatic cancer	0.00191	0.0619	CbGeAlD
Tenofovir—ABCC4—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00188	0.0324	CbGpPWpGaD
Tenofovir—NME2—Nucleotide metabolism—TYMP—pancreatic cancer	0.00167	0.0288	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—SNAI1—pancreatic cancer	0.0015	0.0258	CbGpPWpGaD
Tenofovir—NME2—Nucleotide metabolism—DPYD—pancreatic cancer	0.00133	0.0228	CbGpPWpGaD
Tenofovir—Adenosine triphosphate—HSPA1B—pancreatic cancer	0.00131	0.128	CrCbGaD
Tenofovir—Adenosine triphosphate—ACVR1B—pancreatic cancer	0.00131	0.128	CrCbGaD
Tenofovir—NME1—Nucleotide metabolism—TYMP—pancreatic cancer	0.00127	0.0218	CbGpPWpGaD
Tenofovir—Adenosine triphosphate—HSPA1A—pancreatic cancer	0.0012	0.117	CrCbGaD
Tenofovir—NME1—Loperamide—Tamoxifen—pancreatic cancer	0.00118	0.3	CbGdCrCtD
Tenofovir—ABCC4—Ectoderm Differentiation—LY6E—pancreatic cancer	0.00114	0.0196	CbGpPWpGaD
Tenofovir—AK2—Nucleotide metabolism—TYMS—pancreatic cancer	0.00109	0.0188	CbGpPWpGaD
Tenofovir—NME1—Arf6 trafficking events—AGTR1—pancreatic cancer	0.00101	0.0174	CbGpPWpGaD
Tenofovir—NME1—Nucleotide metabolism—DPYD—pancreatic cancer	0.00101	0.0173	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000976	0.0168	CbGpPWpGaD
Tenofovir—ABCC4—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000945	0.0163	CbGpPWpGaD
Tenofovir—ABCC10—digestive system—pancreatic cancer	0.000926	0.03	CbGeAlD
Tenofovir—ABCC4—pancreas—pancreatic cancer	0.000899	0.0292	CbGeAlD
Tenofovir—ABCC4—NRF2 pathway—FGF13—pancreatic cancer	0.000827	0.0142	CbGpPWpGaD
Tenofovir—ABCC4—digestive system—pancreatic cancer	0.000768	0.0249	CbGeAlD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—SMAD4—pancreatic cancer	0.000763	0.0131	CbGpPWpGaD
Tenofovir—NME2—Nucleotide metabolism—TYMS—pancreatic cancer	0.000757	0.013	CbGpPWpGaD
Tenofovir—ABCC4—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.00075	0.0129	CbGpPWpGaD
Tenofovir—ABCC2—digestive system—pancreatic cancer	0.000743	0.0241	CbGeAlD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—CDH1—pancreatic cancer	0.000719	0.0124	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000709	0.0122	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—FGF13—pancreatic cancer	0.000697	0.012	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—MET—pancreatic cancer	0.000659	0.0113	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—TERT—pancreatic cancer	0.000653	0.0112	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000618	0.0106	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—EGF—pancreatic cancer	0.000614	0.0106	CbGpPWpGaD
Tenofovir—NME1—Arf6 trafficking events—CDH1—pancreatic cancer	0.000581	0.00999	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—SMAD4—pancreatic cancer	0.000578	0.00994	CbGpPWpGaD
Tenofovir—NME1—Nucleotide metabolism—TYMS—pancreatic cancer	0.000573	0.00986	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CDH1—pancreatic cancer	0.000571	0.00982	CbGpPWpGaD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—CCND1—pancreatic cancer	0.000536	0.00922	CbGpPWpGaD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—CTNNB1—pancreatic cancer	0.000531	0.00913	CbGpPWpGaD
Tenofovir—CYP1A2—digestive system—pancreatic cancer	0.000522	0.0169	CbGeAlD
Tenofovir—ABCC10—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000504	0.00867	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.0005	0.00859	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—TERT—pancreatic cancer	0.000495	0.0085	CbGpPWpGaD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—SRC—pancreatic cancer	0.00048	0.00825	CbGpPWpGaD
Tenofovir—Adenosine triphosphate—AKT1—pancreatic cancer	0.000471	0.0458	CrCbGaD
Tenofovir—Adenosine monophosphate—SRC—pancreatic cancer	0.000464	0.0452	CrCbGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000448	0.00771	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000443	0.00761	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CASP3—pancreatic cancer	0.000437	0.00752	CbGpPWpGaD
Tenofovir—NME1—Arf6 trafficking events—CTNNB1—pancreatic cancer	0.000429	0.00737	CbGpPWpGaD
Tenofovir—ABCC4—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000427	0.00735	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CTNNB1—pancreatic cancer	0.000422	0.00725	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000387	0.00665	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—SRC—pancreatic cancer	0.000381	0.00655	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.00038	0.00654	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000377	0.00648	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—MMP9—pancreatic cancer	0.000366	0.0063	CbGpPWpGaD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—PIK3CA—pancreatic cancer	0.000365	0.00628	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—pancreatic cancer	0.000334	0.00574	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000326	0.0056	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000314	0.00541	CbGpPWpGaD
Tenofovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000313	0.00539	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—MYC—pancreatic cancer	0.000303	0.0052	CbGpPWpGaD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—AKT1—pancreatic cancer	0.000298	0.00513	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000295	0.00506	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PRSS1—pancreatic cancer	0.00029	0.00498	CbGpPWpGaD
Tenofovir—Chest pain—Gemcitabine—pancreatic cancer	0.000289	0.00179	CcSEcCtD
Tenofovir—Arthralgia—Gemcitabine—pancreatic cancer	0.000289	0.00179	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000287	0.00177	CcSEcCtD
Tenofovir—Asthenia—Erlotinib—pancreatic cancer	0.000286	0.00177	CcSEcCtD
Tenofovir—Pruritus—Tamoxifen—pancreatic cancer	0.000285	0.00176	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000285	0.00491	CbGpPWpGaD
Tenofovir—Chest pain—Fluorouracil—pancreatic cancer	0.000284	0.00176	CcSEcCtD
Tenofovir—Myalgia—Fluorouracil—pancreatic cancer	0.000284	0.00176	CcSEcCtD
Tenofovir—Renal impairment—Epirubicin—pancreatic cancer	0.000284	0.00175	CcSEcCtD
Tenofovir—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000282	0.00175	CcSEcCtD
Tenofovir—Pruritus—Erlotinib—pancreatic cancer	0.000282	0.00175	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.00028	0.00482	CbGpPWpGaD
Tenofovir—Nervous system disorder—Irinotecan—pancreatic cancer	0.000279	0.00172	CcSEcCtD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—MMP9—pancreatic cancer	0.000277	0.00477	CbGpPWpGaD
Tenofovir—Hepatitis—Docetaxel—pancreatic cancer	0.000277	0.00171	CcSEcCtD
Tenofovir—Diarrhoea—Tamoxifen—pancreatic cancer	0.000276	0.00171	CcSEcCtD
Tenofovir—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000275	0.0017	CcSEcCtD
Tenofovir—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000273	0.00169	CcSEcCtD
Tenofovir—Abdominal pain—Sunitinib—pancreatic cancer	0.000273	0.00169	CcSEcCtD
Tenofovir—Body temperature increased—Sunitinib—pancreatic cancer	0.000273	0.00169	CcSEcCtD
Tenofovir—Diarrhoea—Erlotinib—pancreatic cancer	0.000273	0.00169	CcSEcCtD
Tenofovir—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000272	0.00168	CcSEcCtD
Tenofovir—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000272	0.00168	CcSEcCtD
Tenofovir—Urethral disorder—Docetaxel—pancreatic cancer	0.000271	0.00168	CcSEcCtD
Tenofovir—Anorexia—Irinotecan—pancreatic cancer	0.000271	0.00168	CcSEcCtD
Tenofovir—Renal failure acute—Doxorubicin—pancreatic cancer	0.000271	0.00167	CcSEcCtD
Tenofovir—Skin disorder—Gemcitabine—pancreatic cancer	0.000269	0.00166	CcSEcCtD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—pancreatic cancer	0.000268	0.00461	CbGpPWpGaD
Tenofovir—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000268	0.00166	CcSEcCtD
Tenofovir—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000267	0.00165	CcSEcCtD
Tenofovir—Dizziness—Tamoxifen—pancreatic cancer	0.000267	0.00165	CcSEcCtD
Tenofovir—Anorexia—Gemcitabine—pancreatic cancer	0.000264	0.00163	CcSEcCtD
Tenofovir—Dizziness—Erlotinib—pancreatic cancer	0.000264	0.00163	CcSEcCtD
Tenofovir—Renal impairment—Doxorubicin—pancreatic cancer	0.000262	0.00162	CcSEcCtD
Tenofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000261	0.0045	CbGpPWpGaD
Tenofovir—Anorexia—Fluorouracil—pancreatic cancer	0.00026	0.00161	CcSEcCtD
Tenofovir—Insomnia—Irinotecan—pancreatic cancer	0.000257	0.00159	CcSEcCtD
Tenofovir—Vomiting—Tamoxifen—pancreatic cancer	0.000256	0.00159	CcSEcCtD
Tenofovir—Hypersensitivity—Sunitinib—pancreatic cancer	0.000255	0.00157	CcSEcCtD
Tenofovir—Rash—Tamoxifen—pancreatic cancer	0.000254	0.00157	CcSEcCtD
Tenofovir—Dermatitis—Tamoxifen—pancreatic cancer	0.000254	0.00157	CcSEcCtD
Tenofovir—Vomiting—Erlotinib—pancreatic cancer	0.000254	0.00157	CcSEcCtD
Tenofovir—Dyspnoea—Irinotecan—pancreatic cancer	0.000254	0.00157	CcSEcCtD
Tenofovir—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000253	0.00156	CcSEcCtD
Tenofovir—Headache—Tamoxifen—pancreatic cancer	0.000253	0.00156	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000253	0.00156	CcSEcCtD
Tenofovir—Rash—Erlotinib—pancreatic cancer	0.000252	0.00156	CcSEcCtD
Tenofovir—Dermatitis—Erlotinib—pancreatic cancer	0.000251	0.00155	CcSEcCtD
Tenofovir—AK2—Metabolism—ARG2—pancreatic cancer	0.000251	0.00432	CbGpPWpGaD
Tenofovir—Insomnia—Gemcitabine—pancreatic cancer	0.000251	0.00155	CcSEcCtD
Tenofovir—Dyspepsia—Irinotecan—pancreatic cancer	0.00025	0.00155	CcSEcCtD
Tenofovir—Immune system disorder—Docetaxel—pancreatic cancer	0.00025	0.00155	CcSEcCtD
Tenofovir—Headache—Erlotinib—pancreatic cancer	0.00025	0.00155	CcSEcCtD
Tenofovir—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00025	0.00154	CcSEcCtD
Tenofovir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000249	0.00428	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—TP53—pancreatic cancer	0.000248	0.00427	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000248	0.00153	CcSEcCtD
Tenofovir—Asthenia—Sunitinib—pancreatic cancer	0.000248	0.00153	CcSEcCtD
Tenofovir—Decreased appetite—Irinotecan—pancreatic cancer	0.000247	0.00153	CcSEcCtD
Tenofovir—Dyspnoea—Gemcitabine—pancreatic cancer	0.000247	0.00153	CcSEcCtD
Tenofovir—Insomnia—Fluorouracil—pancreatic cancer	0.000246	0.00152	CcSEcCtD
Tenofovir—Hypokalaemia—Epirubicin—pancreatic cancer	0.000246	0.00152	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000246	0.00152	CcSEcCtD
Tenofovir—Fatigue—Irinotecan—pancreatic cancer	0.000245	0.00152	CcSEcCtD
Tenofovir—Pruritus—Sunitinib—pancreatic cancer	0.000244	0.00151	CcSEcCtD
Tenofovir—Pain—Irinotecan—pancreatic cancer	0.000243	0.0015	CcSEcCtD
Tenofovir—Dyspnoea—Fluorouracil—pancreatic cancer	0.000243	0.0015	CcSEcCtD
Tenofovir—Mental disorder—Docetaxel—pancreatic cancer	0.000243	0.0015	CcSEcCtD
Tenofovir—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000241	0.00149	CcSEcCtD
Tenofovir—Malnutrition—Docetaxel—pancreatic cancer	0.000241	0.00149	CcSEcCtD
Tenofovir—Decreased appetite—Gemcitabine—pancreatic cancer	0.000241	0.00149	CcSEcCtD
Tenofovir—Dyspepsia—Fluorouracil—pancreatic cancer	0.00024	0.00148	CcSEcCtD
Tenofovir—Nausea—Tamoxifen—pancreatic cancer	0.00024	0.00148	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000239	0.00148	CcSEcCtD
Tenofovir—Fatigue—Gemcitabine—pancreatic cancer	0.000239	0.00148	CcSEcCtD
Tenofovir—Muscular weakness—Epirubicin—pancreatic cancer	0.000238	0.00147	CcSEcCtD
Tenofovir—Pain—Gemcitabine—pancreatic cancer	0.000237	0.00147	CcSEcCtD
Tenofovir—Nausea—Erlotinib—pancreatic cancer	0.000237	0.00147	CcSEcCtD
Tenofovir—Decreased appetite—Fluorouracil—pancreatic cancer	0.000237	0.00146	CcSEcCtD
Tenofovir—Diarrhoea—Sunitinib—pancreatic cancer	0.000236	0.00146	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000235	0.00145	CcSEcCtD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000235	0.00404	CbGpPWpGaD
Tenofovir—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000234	0.00145	CcSEcCtD
Tenofovir—Back pain—Docetaxel—pancreatic cancer	0.000233	0.00144	CcSEcCtD
Tenofovir—Pain—Fluorouracil—pancreatic cancer	0.000233	0.00144	CcSEcCtD
Tenofovir—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000233	0.00144	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—NFE2L2—pancreatic cancer	0.000232	0.00399	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—MYC—pancreatic cancer	0.000229	0.00394	CbGpPWpGaD
Tenofovir—Pancreatitis—Epirubicin—pancreatic cancer	0.000229	0.00141	CcSEcCtD
Tenofovir—Dizziness—Sunitinib—pancreatic cancer	0.000228	0.00141	CcSEcCtD
Tenofovir—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000227	0.00141	CcSEcCtD
Tenofovir—ABCC4—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000225	0.00387	CbGpPWpGaD
Tenofovir—Body temperature increased—Irinotecan—pancreatic cancer	0.000225	0.00139	CcSEcCtD
Tenofovir—Abdominal pain—Irinotecan—pancreatic cancer	0.000225	0.00139	CcSEcCtD
Tenofovir—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000223	0.00138	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—TGFA—pancreatic cancer	0.000221	0.0038	CbGpPWpGaD
Tenofovir—Muscular weakness—Doxorubicin—pancreatic cancer	0.00022	0.00136	CcSEcCtD
Tenofovir—Vomiting—Sunitinib—pancreatic cancer	0.00022	0.00136	CcSEcCtD
Tenofovir—AK2—Metabolism—TYMP—pancreatic cancer	0.000219	0.00377	CbGpPWpGaD
Tenofovir—Body temperature increased—Gemcitabine—pancreatic cancer	0.000219	0.00135	CcSEcCtD
Tenofovir—Rash—Sunitinib—pancreatic cancer	0.000218	0.00135	CcSEcCtD
Tenofovir—Dermatitis—Sunitinib—pancreatic cancer	0.000218	0.00135	CcSEcCtD
Tenofovir—ABCC4—Ectoderm Differentiation—SHH—pancreatic cancer	0.000218	0.00374	CbGpPWpGaD
Tenofovir—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000217	0.00134	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—SLC2A2—pancreatic cancer	0.000216	0.00372	CbGpPWpGaD
Tenofovir—Headache—Sunitinib—pancreatic cancer	0.000216	0.00134	CcSEcCtD
Tenofovir—Body temperature increased—Fluorouracil—pancreatic cancer	0.000215	0.00133	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000212	0.00365	CbGpPWpGaD
Tenofovir—Pancreatitis—Doxorubicin—pancreatic cancer	0.000212	0.00131	CcSEcCtD
Tenofovir—Weight decreased—Epirubicin—pancreatic cancer	0.000211	0.0013	CcSEcCtD
Tenofovir—Hyperglycaemia—Epirubicin—pancreatic cancer	0.00021	0.0013	CcSEcCtD
Tenofovir—Hypersensitivity—Irinotecan—pancreatic cancer	0.00021	0.0013	CcSEcCtD
Tenofovir—Pneumonia—Epirubicin—pancreatic cancer	0.000209	0.00129	CcSEcCtD
Tenofovir—Infestation—Epirubicin—pancreatic cancer	0.000208	0.00129	CcSEcCtD
Tenofovir—Infestation NOS—Epirubicin—pancreatic cancer	0.000208	0.00129	CcSEcCtD
Tenofovir—Chest pain—Docetaxel—pancreatic cancer	0.000205	0.00127	CcSEcCtD
Tenofovir—Myalgia—Docetaxel—pancreatic cancer	0.000205	0.00127	CcSEcCtD
Tenofovir—Arthralgia—Docetaxel—pancreatic cancer	0.000205	0.00127	CcSEcCtD
Tenofovir—Nausea—Sunitinib—pancreatic cancer	0.000205	0.00127	CcSEcCtD
Tenofovir—Renal failure—Epirubicin—pancreatic cancer	0.000204	0.00126	CcSEcCtD
Tenofovir—Asthenia—Irinotecan—pancreatic cancer	0.000204	0.00126	CcSEcCtD
Tenofovir—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000204	0.00126	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000204	0.00126	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000203	0.0035	CbGpPWpGaD
Tenofovir—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000201	0.00124	CcSEcCtD
Tenofovir—NME2—Metabolism—PRSS1—pancreatic cancer	0.000201	0.00345	CbGpPWpGaD
Tenofovir—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000201	0.00124	CcSEcCtD
Tenofovir—Sweating—Epirubicin—pancreatic cancer	0.000199	0.00123	CcSEcCtD
Tenofovir—Asthenia—Gemcitabine—pancreatic cancer	0.000199	0.00123	CcSEcCtD
Tenofovir—Haematuria—Epirubicin—pancreatic cancer	0.000198	0.00123	CcSEcCtD
Tenofovir—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000197	0.00122	CcSEcCtD
Tenofovir—Pruritus—Gemcitabine—pancreatic cancer	0.000196	0.00121	CcSEcCtD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000196	0.00337	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—NFE2L2—pancreatic cancer	0.000196	0.00336	CbGpPWpGaD
Tenofovir—Weight decreased—Doxorubicin—pancreatic cancer	0.000195	0.00121	CcSEcCtD
Tenofovir—Sinusitis—Epirubicin—pancreatic cancer	0.000195	0.00121	CcSEcCtD
Tenofovir—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000195	0.0012	CcSEcCtD
Tenofovir—Diarrhoea—Irinotecan—pancreatic cancer	0.000195	0.0012	CcSEcCtD
Tenofovir—Pneumonia—Doxorubicin—pancreatic cancer	0.000194	0.0012	CcSEcCtD
Tenofovir—Nervous system disorder—Docetaxel—pancreatic cancer	0.000193	0.00119	CcSEcCtD
Tenofovir—Pruritus—Fluorouracil—pancreatic cancer	0.000193	0.00119	CcSEcCtD
Tenofovir—Infestation NOS—Doxorubicin—pancreatic cancer	0.000192	0.00119	CcSEcCtD
Tenofovir—Infestation—Doxorubicin—pancreatic cancer	0.000192	0.00119	CcSEcCtD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000191	0.00329	CbGpPWpGaD
Tenofovir—Skin disorder—Docetaxel—pancreatic cancer	0.000191	0.00118	CcSEcCtD
Tenofovir—ABCC10—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.00019	0.00327	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00019	0.00326	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—AHR—pancreatic cancer	0.00019	0.00326	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—pancreatic cancer	0.00019	0.00326	CbGpPWpGaD
Tenofovir—Diarrhoea—Gemcitabine—pancreatic cancer	0.00019	0.00117	CcSEcCtD
Tenofovir—Renal failure—Doxorubicin—pancreatic cancer	0.000189	0.00117	CcSEcCtD
Tenofovir—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000189	0.00117	CcSEcCtD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—TP53—pancreatic cancer	0.000188	0.00324	CbGpPWpGaD
Tenofovir—Dizziness—Irinotecan—pancreatic cancer	0.000188	0.00116	CcSEcCtD
Tenofovir—Anorexia—Docetaxel—pancreatic cancer	0.000187	0.00116	CcSEcCtD
Tenofovir—Hepatitis—Epirubicin—pancreatic cancer	0.000187	0.00115	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—TGFA—pancreatic cancer	0.000187	0.00321	CbGpPWpGaD
Tenofovir—Diarrhoea—Fluorouracil—pancreatic cancer	0.000186	0.00115	CcSEcCtD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—pancreatic cancer	0.000185	0.00318	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—pancreatic cancer	0.000185	0.00318	CbGpPWpGaD
Tenofovir—Sweating—Doxorubicin—pancreatic cancer	0.000185	0.00114	CcSEcCtD
Tenofovir—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000184	0.00114	CcSEcCtD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000184	0.00316	CbGpPWpGaD
Tenofovir—Haematuria—Doxorubicin—pancreatic cancer	0.000184	0.00113	CcSEcCtD
Tenofovir—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000184	0.00113	CcSEcCtD
Tenofovir—Urethral disorder—Epirubicin—pancreatic cancer	0.000183	0.00113	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—SLC2A2—pancreatic cancer	0.000183	0.00314	CbGpPWpGaD
Tenofovir—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000182	0.00113	CcSEcCtD
Tenofovir—Vomiting—Irinotecan—pancreatic cancer	0.000181	0.00112	CcSEcCtD
Tenofovir—Sinusitis—Doxorubicin—pancreatic cancer	0.000181	0.00112	CcSEcCtD
Tenofovir—Dizziness—Fluorouracil—pancreatic cancer	0.00018	0.00111	CcSEcCtD
Tenofovir—Rash—Irinotecan—pancreatic cancer	0.000179	0.00111	CcSEcCtD
Tenofovir—Dermatitis—Irinotecan—pancreatic cancer	0.000179	0.00111	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000179	0.00111	CcSEcCtD
Tenofovir—Headache—Irinotecan—pancreatic cancer	0.000178	0.0011	CcSEcCtD
Tenofovir—Insomnia—Docetaxel—pancreatic cancer	0.000178	0.0011	CcSEcCtD
Tenofovir—AK2—Metabolism—GLP1R—pancreatic cancer	0.000177	0.00304	CbGpPWpGaD
Tenofovir—Vomiting—Gemcitabine—pancreatic cancer	0.000176	0.00109	CcSEcCtD
Tenofovir—Dyspnoea—Docetaxel—pancreatic cancer	0.000175	0.00108	CcSEcCtD
Tenofovir—Rash—Gemcitabine—pancreatic cancer	0.000175	0.00108	CcSEcCtD
Tenofovir—Dermatitis—Gemcitabine—pancreatic cancer	0.000175	0.00108	CcSEcCtD
Tenofovir—AK2—Metabolism—DPYD—pancreatic cancer	0.000174	0.00299	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ARG2—pancreatic cancer	0.000174	0.00299	CbGpPWpGaD
Tenofovir—Headache—Gemcitabine—pancreatic cancer	0.000174	0.00107	CcSEcCtD
Tenofovir—Vomiting—Fluorouracil—pancreatic cancer	0.000173	0.00107	CcSEcCtD
Tenofovir—Dyspepsia—Docetaxel—pancreatic cancer	0.000173	0.00107	CcSEcCtD
Tenofovir—Hepatitis—Doxorubicin—pancreatic cancer	0.000173	0.00107	CcSEcCtD
Tenofovir—Rash—Fluorouracil—pancreatic cancer	0.000172	0.00106	CcSEcCtD
Tenofovir—Dermatitis—Fluorouracil—pancreatic cancer	0.000172	0.00106	CcSEcCtD
Tenofovir—Decreased appetite—Docetaxel—pancreatic cancer	0.000171	0.00106	CcSEcCtD
Tenofovir—Headache—Fluorouracil—pancreatic cancer	0.000171	0.00106	CcSEcCtD
Tenofovir—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000171	0.00105	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00017	0.00105	CcSEcCtD
Tenofovir—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00017	0.00105	CcSEcCtD
Tenofovir—Fatigue—Docetaxel—pancreatic cancer	0.00017	0.00105	CcSEcCtD
Tenofovir—Urethral disorder—Doxorubicin—pancreatic cancer	0.000169	0.00105	CcSEcCtD
Tenofovir—Nausea—Irinotecan—pancreatic cancer	0.000169	0.00104	CcSEcCtD
Tenofovir—Immune system disorder—Epirubicin—pancreatic cancer	0.000169	0.00104	CcSEcCtD
Tenofovir—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000168	0.00104	CcSEcCtD
Tenofovir—Pain—Docetaxel—pancreatic cancer	0.000168	0.00104	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—HSPA1A—pancreatic cancer	0.000166	0.00286	CbGpPWpGaD
Tenofovir—AK2—Metabolism—SLC2A2—pancreatic cancer	0.000165	0.00284	CbGpPWpGaD
Tenofovir—Nausea—Gemcitabine—pancreatic cancer	0.000165	0.00102	CcSEcCtD
Tenofovir—Mental disorder—Epirubicin—pancreatic cancer	0.000164	0.00101	CcSEcCtD
Tenofovir—Malnutrition—Epirubicin—pancreatic cancer	0.000163	0.001	CcSEcCtD
Tenofovir—Nausea—Fluorouracil—pancreatic cancer	0.000162	0.001	CcSEcCtD
Tenofovir—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000161	0.000994	CcSEcCtD
Tenofovir—Flatulence—Epirubicin—pancreatic cancer	0.00016	0.00099	CcSEcCtD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00016	0.00275	CbGpPWpGaD
Tenofovir—Back pain—Epirubicin—pancreatic cancer	0.000157	0.000972	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000156	0.00268	CbGpPWpGaD
Tenofovir—Immune system disorder—Doxorubicin—pancreatic cancer	0.000156	0.000965	CcSEcCtD
Tenofovir—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000156	0.000963	CcSEcCtD
Tenofovir—Body temperature increased—Docetaxel—pancreatic cancer	0.000155	0.000961	CcSEcCtD
Tenofovir—Abdominal pain—Docetaxel—pancreatic cancer	0.000155	0.000961	CcSEcCtD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000155	0.00266	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—EGF—pancreatic cancer	0.000153	0.00262	CbGpPWpGaD
Tenofovir—NME2—Metabolism—TYMP—pancreatic cancer	0.000152	0.00262	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PRSS1—pancreatic cancer	0.000152	0.00262	CbGpPWpGaD
Tenofovir—Mental disorder—Doxorubicin—pancreatic cancer	0.000151	0.000936	CcSEcCtD
Tenofovir—Malnutrition—Doxorubicin—pancreatic cancer	0.00015	0.00093	CcSEcCtD
Tenofovir—Flatulence—Doxorubicin—pancreatic cancer	0.000148	0.000916	CcSEcCtD
Tenofovir—Back pain—Doxorubicin—pancreatic cancer	0.000145	0.000899	CcSEcCtD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—EGF—pancreatic cancer	0.000145	0.0025	CbGpPWpGaD
Tenofovir—Hypersensitivity—Docetaxel—pancreatic cancer	0.000145	0.000896	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000145	0.00249	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000142	0.00245	CbGpPWpGaD
Tenofovir—ABCC4—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000142	0.00244	CbGpPWpGaD
Tenofovir—Asthenia—Docetaxel—pancreatic cancer	0.000141	0.000872	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000141	0.00243	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—HSPA1A—pancreatic cancer	0.00014	0.00241	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.00014	0.0024	CbGpPWpGaD
Tenofovir—Pruritus—Docetaxel—pancreatic cancer	0.000139	0.00086	CcSEcCtD
Tenofovir—ABCC4—Ectoderm Differentiation—SMAD4—pancreatic cancer	0.000138	0.00238	CbGpPWpGaD
Tenofovir—Chest pain—Epirubicin—pancreatic cancer	0.000138	0.000855	CcSEcCtD
Tenofovir—Arthralgia—Epirubicin—pancreatic cancer	0.000138	0.000855	CcSEcCtD
Tenofovir—Myalgia—Epirubicin—pancreatic cancer	0.000138	0.000855	CcSEcCtD
Tenofovir—Anxiety—Epirubicin—pancreatic cancer	0.000138	0.000853	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000137	0.00085	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000136	0.00234	CbGpPWpGaD
Tenofovir—Diarrhoea—Docetaxel—pancreatic cancer	0.000135	0.000832	CcSEcCtD
Tenofovir—NME1—Metabolism—ARG2—pancreatic cancer	0.000132	0.00227	CbGpPWpGaD
Tenofovir—Nervous system disorder—Epirubicin—pancreatic cancer	0.00013	0.000804	CcSEcCtD
Tenofovir—Dizziness—Docetaxel—pancreatic cancer	0.00013	0.000804	CcSEcCtD
Tenofovir—Skin disorder—Epirubicin—pancreatic cancer	0.000129	0.000797	CcSEcCtD
Tenofovir—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000128	0.000793	CcSEcCtD
Tenofovir—Chest pain—Doxorubicin—pancreatic cancer	0.000128	0.000792	CcSEcCtD
Tenofovir—Arthralgia—Doxorubicin—pancreatic cancer	0.000128	0.000792	CcSEcCtD
Tenofovir—Myalgia—Doxorubicin—pancreatic cancer	0.000128	0.000792	CcSEcCtD
Tenofovir—AK2—Metabolism—CD44—pancreatic cancer	0.000128	0.0022	CbGpPWpGaD
Tenofovir—Anxiety—Doxorubicin—pancreatic cancer	0.000128	0.000789	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000127	0.000786	CcSEcCtD
Tenofovir—Anorexia—Epirubicin—pancreatic cancer	0.000126	0.000782	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000126	0.00217	CbGpPWpGaD
Tenofovir—Vomiting—Docetaxel—pancreatic cancer	0.000125	0.000773	CcSEcCtD
Tenofovir—Rash—Docetaxel—pancreatic cancer	0.000124	0.000767	CcSEcCtD
Tenofovir—Dermatitis—Docetaxel—pancreatic cancer	0.000124	0.000766	CcSEcCtD
Tenofovir—CYP1A2—Estrogen Receptor Pathway—STAT3—pancreatic cancer	0.000124	0.00213	CbGpPWpGaD
Tenofovir—Headache—Docetaxel—pancreatic cancer	0.000123	0.000762	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000123	0.00211	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GCG—pancreatic cancer	0.000123	0.00211	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GLP1R—pancreatic cancer	0.000123	0.00211	CbGpPWpGaD
Tenofovir—CYP1A2—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000122	0.0021	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000121	0.000747	CcSEcCtD
Tenofovir—NME2—Metabolism—DPYD—pancreatic cancer	0.000121	0.00207	CbGpPWpGaD
Tenofovir—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00012	0.000744	CcSEcCtD
Tenofovir—Insomnia—Epirubicin—pancreatic cancer	0.00012	0.000742	CcSEcCtD
Tenofovir—Skin disorder—Doxorubicin—pancreatic cancer	0.000119	0.000737	CcSEcCtD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000119	0.00204	CbGpPWpGaD
Tenofovir—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000119	0.000734	CcSEcCtD
Tenofovir—Dyspnoea—Epirubicin—pancreatic cancer	0.000118	0.000731	CcSEcCtD
Tenofovir—Anorexia—Doxorubicin—pancreatic cancer	0.000117	0.000723	CcSEcCtD
Tenofovir—Nausea—Docetaxel—pancreatic cancer	0.000117	0.000722	CcSEcCtD
Tenofovir—Dyspepsia—Epirubicin—pancreatic cancer	0.000117	0.000722	CcSEcCtD
Tenofovir—Decreased appetite—Epirubicin—pancreatic cancer	0.000115	0.000713	CcSEcCtD
Tenofovir—AK2—Metabolism—STK11—pancreatic cancer	0.000115	0.00198	CbGpPWpGaD
Tenofovir—NME1—Metabolism—TYMP—pancreatic cancer	0.000115	0.00198	CbGpPWpGaD
Tenofovir—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000115	0.000708	CcSEcCtD
Tenofovir—NME2—Metabolism—SLC2A2—pancreatic cancer	0.000114	0.00197	CbGpPWpGaD
Tenofovir—Fatigue—Epirubicin—pancreatic cancer	0.000114	0.000707	CcSEcCtD
Tenofovir—Pain—Epirubicin—pancreatic cancer	0.000113	0.000701	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000113	0.00195	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000113	0.00194	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000112	0.000691	CcSEcCtD
Tenofovir—Insomnia—Doxorubicin—pancreatic cancer	0.000111	0.000686	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000111	0.0019	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IFNA5—pancreatic cancer	0.00011	0.00189	CbGpPWpGaD
Tenofovir—Dyspnoea—Doxorubicin—pancreatic cancer	0.000109	0.000677	CcSEcCtD
Tenofovir—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000108	0.000671	CcSEcCtD
Tenofovir—Dyspepsia—Doxorubicin—pancreatic cancer	0.000108	0.000668	CcSEcCtD
Tenofovir—Decreased appetite—Doxorubicin—pancreatic cancer	0.000107	0.00066	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000106	0.000655	CcSEcCtD
Tenofovir—Fatigue—Doxorubicin—pancreatic cancer	0.000106	0.000654	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000105	0.00181	CbGpPWpGaD
Tenofovir—Pain—Doxorubicin—pancreatic cancer	0.000105	0.000649	CcSEcCtD
Tenofovir—Abdominal pain—Epirubicin—pancreatic cancer	0.000105	0.000648	CcSEcCtD
Tenofovir—Body temperature increased—Epirubicin—pancreatic cancer	0.000105	0.000648	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000105	0.0018	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PPP2R5B—pancreatic cancer	0.000104	0.00178	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—pancreatic cancer	0.000103	0.00177	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.0001	0.000621	CcSEcCtD
Tenofovir—AK2—Metabolism—TYMS—pancreatic cancer	9.92e-05	0.00171	CbGpPWpGaD
Tenofovir—Hypersensitivity—Epirubicin—pancreatic cancer	9.77e-05	0.000604	CcSEcCtD
Tenofovir—Abdominal pain—Doxorubicin—pancreatic cancer	9.7e-05	0.0006	CcSEcCtD
Tenofovir—Body temperature increased—Doxorubicin—pancreatic cancer	9.7e-05	0.0006	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	9.6e-05	0.00165	CbGpPWpGaD
Tenofovir—Asthenia—Epirubicin—pancreatic cancer	9.52e-05	0.000588	CcSEcCtD
Tenofovir—Pruritus—Epirubicin—pancreatic cancer	9.39e-05	0.00058	CcSEcCtD
Tenofovir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	9.35e-05	0.00161	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GLP1R—pancreatic cancer	9.29e-05	0.0016	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	9.29e-05	0.0016	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—VEGFA—pancreatic cancer	9.23e-05	0.00159	CbGpPWpGaD
Tenofovir—NME1—Metabolism—DPYD—pancreatic cancer	9.14e-05	0.00157	CbGpPWpGaD
Tenofovir—Diarrhoea—Epirubicin—pancreatic cancer	9.08e-05	0.000561	CcSEcCtD
Tenofovir—Hypersensitivity—Doxorubicin—pancreatic cancer	9.04e-05	0.000559	CcSEcCtD
Tenofovir—NME2—Metabolism—CD44—pancreatic cancer	8.87e-05	0.00152	CbGpPWpGaD
Tenofovir—Asthenia—Doxorubicin—pancreatic cancer	8.81e-05	0.000544	CcSEcCtD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	8.8e-05	0.00151	CbGpPWpGaD
Tenofovir—Dizziness—Epirubicin—pancreatic cancer	8.77e-05	0.000542	CcSEcCtD
Tenofovir—Pruritus—Doxorubicin—pancreatic cancer	8.69e-05	0.000537	CcSEcCtD
Tenofovir—NME1—Metabolism—SLC2A2—pancreatic cancer	8.68e-05	0.00149	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GCG—pancreatic cancer	8.5e-05	0.00146	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—TGFB1—pancreatic cancer	8.47e-05	0.00146	CbGpPWpGaD
Tenofovir—Vomiting—Epirubicin—pancreatic cancer	8.44e-05	0.000521	CcSEcCtD
Tenofovir—Diarrhoea—Doxorubicin—pancreatic cancer	8.4e-05	0.000519	CcSEcCtD
Tenofovir—Rash—Epirubicin—pancreatic cancer	8.37e-05	0.000517	CcSEcCtD
Tenofovir—Dermatitis—Epirubicin—pancreatic cancer	8.36e-05	0.000517	CcSEcCtD
Tenofovir—Headache—Epirubicin—pancreatic cancer	8.31e-05	0.000514	CcSEcCtD
Tenofovir—Dizziness—Doxorubicin—pancreatic cancer	8.12e-05	0.000502	CcSEcCtD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	8.07e-05	0.00139	CbGpPWpGaD
Tenofovir—AK2—Metabolism—APOE—pancreatic cancer	8.07e-05	0.00139	CbGpPWpGaD
Tenofovir—NME2—Metabolism—STK11—pancreatic cancer	7.99e-05	0.00137	CbGpPWpGaD
Tenofovir—Nausea—Epirubicin—pancreatic cancer	7.88e-05	0.000487	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	7.85e-05	0.00135	CbGpPWpGaD
Tenofovir—Vomiting—Doxorubicin—pancreatic cancer	7.81e-05	0.000482	CcSEcCtD
Tenofovir—Rash—Doxorubicin—pancreatic cancer	7.74e-05	0.000478	CcSEcCtD
Tenofovir—Dermatitis—Doxorubicin—pancreatic cancer	7.73e-05	0.000478	CcSEcCtD
Tenofovir—Headache—Doxorubicin—pancreatic cancer	7.69e-05	0.000475	CcSEcCtD
Tenofovir—Nausea—Doxorubicin—pancreatic cancer	7.29e-05	0.000451	CcSEcCtD
Tenofovir—AK2—Metabolism—PIK3CG—pancreatic cancer	7.28e-05	0.00125	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	7.23e-05	0.00124	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	7.03e-05	0.00121	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PPARG—pancreatic cancer	7.03e-05	0.00121	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.93e-05	0.00119	CbGpPWpGaD
Tenofovir—NME2—Metabolism—TYMS—pancreatic cancer	6.87e-05	0.00118	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	6.85e-05	0.00118	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—CTNNB1—pancreatic cancer	6.78e-05	0.00117	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	6.77e-05	0.00116	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CD44—pancreatic cancer	6.72e-05	0.00116	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GCG—pancreatic cancer	6.44e-05	0.00111	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CD—pancreatic cancer	6.4e-05	0.0011	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CD44—pancreatic cancer	6.2e-05	0.00107	CbGpPWpGaD
Tenofovir—NME1—Metabolism—STK11—pancreatic cancer	6.06e-05	0.00104	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.04e-05	0.00104	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	6.02e-05	0.00104	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IFNA1—pancreatic cancer	6.01e-05	0.00103	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.85e-05	0.00101	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	5.78e-05	0.000993	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IFNA2—pancreatic cancer	5.59e-05	0.000961	CbGpPWpGaD
Tenofovir—NME2—Metabolism—APOE—pancreatic cancer	5.59e-05	0.000961	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CB—pancreatic cancer	5.58e-05	0.000959	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTGS2—pancreatic cancer	5.53e-05	0.00095	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—MYC—pancreatic cancer	5.49e-05	0.000945	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	5.4e-05	0.000929	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	5.25e-05	0.000902	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—TGFB1—pancreatic cancer	5.24e-05	0.000901	CbGpPWpGaD
Tenofovir—NME1—Metabolism—TYMS—pancreatic cancer	5.21e-05	0.000896	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CG—pancreatic cancer	5.05e-05	0.000868	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PPARG—pancreatic cancer	4.87e-05	0.000837	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTEN—pancreatic cancer	4.82e-05	0.000829	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	4.67e-05	0.000803	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	4.67e-05	0.000803	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	4.55e-05	0.000782	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	4.49e-05	0.000773	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CD—pancreatic cancer	4.44e-05	0.000763	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—TGFB1—pancreatic cancer	4.42e-05	0.00076	CbGpPWpGaD
Tenofovir—NME1—Metabolism—APOE—pancreatic cancer	4.24e-05	0.000729	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	4.21e-05	0.000723	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	4.19e-05	0.00072	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	4.18e-05	0.000718	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	4.1e-05	0.000704	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	4.09e-05	0.000704	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	4.09e-05	0.000704	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PLAU—pancreatic cancer	3.97e-05	0.000682	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	3.9e-05	0.000671	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	3.9e-05	0.000671	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	3.87e-05	0.000665	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CB—pancreatic cancer	3.87e-05	0.000665	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTGS2—pancreatic cancer	3.83e-05	0.000659	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CG—pancreatic cancer	3.82e-05	0.000658	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	3.76e-05	0.000646	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PPARG—pancreatic cancer	3.69e-05	0.000635	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CG—pancreatic cancer	3.53e-05	0.000607	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—EGF—pancreatic cancer	3.49e-05	0.0006	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CA—pancreatic cancer	3.4e-05	0.000585	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CD—pancreatic cancer	3.36e-05	0.000578	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTEN—pancreatic cancer	3.34e-05	0.000574	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	3.29e-05	0.000565	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	3.2e-05	0.00055	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CD—pancreatic cancer	3.1e-05	0.000534	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CB—pancreatic cancer	2.93e-05	0.000504	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTGS2—pancreatic cancer	2.9e-05	0.000499	CbGpPWpGaD
Tenofovir—AK2—Metabolism—AKT1—pancreatic cancer	2.78e-05	0.000478	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CB—pancreatic cancer	2.7e-05	0.000465	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	2.61e-05	0.000449	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTEN—pancreatic cancer	2.53e-05	0.000435	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CA—pancreatic cancer	2.36e-05	0.000405	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SRC—pancreatic cancer	2.17e-05	0.000373	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—VEGFA—pancreatic cancer	2.11e-05	0.000363	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—NRAS—pancreatic cancer	2.09e-05	0.000359	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TGFB1—pancreatic cancer	1.94e-05	0.000333	CbGpPWpGaD
Tenofovir—NME2—Metabolism—AKT1—pancreatic cancer	1.93e-05	0.000331	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PRSS1—pancreatic cancer	1.8e-05	0.00031	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—KRAS—pancreatic cancer	1.79e-05	0.000309	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CA—pancreatic cancer	1.79e-05	0.000307	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CA—pancreatic cancer	1.65e-05	0.000284	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—pancreatic cancer	1.6e-05	0.000274	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.56e-05	0.000269	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HRAS—pancreatic cancer	1.53e-05	0.000262	CbGpPWpGaD
Tenofovir—NME1—Metabolism—AKT1—pancreatic cancer	1.46e-05	0.000251	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TYMP—pancreatic cancer	1.37e-05	0.000235	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—AKT1—pancreatic cancer	1.35e-05	0.000232	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.13e-05	0.000194	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GLP1R—pancreatic cancer	1.1e-05	0.000189	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—DPYD—pancreatic cancer	1.08e-05	0.000186	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	1.03e-05	0.000177	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.02e-05	0.000175	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.82e-06	0.000169	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.94e-06	0.000154	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CD44—pancreatic cancer	7.96e-06	0.000137	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.79e-06	0.000134	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.72e-06	0.000133	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GCG—pancreatic cancer	7.63e-06	0.000131	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—STK11—pancreatic cancer	7.17e-06	0.000123	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.74e-06	0.000116	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TYMS—pancreatic cancer	6.17e-06	0.000106	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—APOE—pancreatic cancer	5.02e-06	8.63e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.75e-06	8.17e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	4.53e-06	7.79e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PPARG—pancreatic cancer	4.37e-06	7.52e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	3.98e-06	6.85e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	3.47e-06	5.97e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTGS2—pancreatic cancer	3.44e-06	5.91e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTEN—pancreatic cancer	3e-06	5.16e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	2.12e-06	3.64e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.73e-06	2.97e-05	CbGpPWpGaD
